Rapid identification of Stenotrophomonas maltophilia by peptide nucleic acid fluorescence in situ hybridization

New Microbes and New Infections

Volumn 2, Issue 3, 2014, Pages 79-81

  Hansen, N ^a   Rasmussen, A K I ^b   Fiandaca, M J ^c   Kragh, K N ^a   Bjarnsholt, T ^a,d   Hoiby N ^a,d   Stender, H ^e   Guardabassi, L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AGILENT TECHNOLOGIES   (United States)

^c AdvanDx Inc   (United States)

^d Mental Health Services CPH   (Denmark)

^e Stender Diagnostics   (Denmark)

Author keywords

Cystic fibrosis; Identification; PNA FISH; Stenotrophomonas maltophilia

Indexed keywords

PEPTIDE NUCLEIC ACID; RNA 16S; FLUORESCEIN ISOTHIOCYANATE;

ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CROSS REACTION; CYSTIC FIBROSIS; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; HUMAN; LUNG LAVAGE; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SENSITIVITY AND SPECIFICITY; STENOTROPHOMONAS MALTOPHILIA; TRACHEAL ASPIRATION PROCEDURE; DISEASE ASSOCIATION; PEPTIDE NUCLEIC ACID FLUORESCENCE IN SITU HYBRIDIZATION; RNA HYBRIDIZATION;

BACTERIA (MICROORGANISMS); EQUIDAE; STENOTROPHOMONAS MALTOPHILIA;

EID: 84920713409     PISSN: 20522975     EISSN: None     Source Type: Journal    
DOI: 10.1002/nmi2.38     Document Type: Article

References (20)

1. Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 2012; 25: 2-41.
2. Dalboge CS, Hansen CR, Pressler T, Hoiby N, Johansen HK. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. J Cyst Fibros 2011; 10: 318-325.
3. Ryan RP, Monchy S, Cardinale M et al. The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat Rev Microbiol 2009; 7: 514-525.
4. Albini S, Abril C, Franchini M, Huessy D, Filioussis G. Stenotrophomonas maltophilia isolated from the airways of animals with chronic respiratory disease. Schweiz Arch Tierheilkd 2009; 151: 323-328.
5. Winther L, Andersen RM, Baptiste KE, Aalbaek B, Guardabassi L. Association of Stenotrophomonas maltophilia infection with lower airway disease in the horse: a retrospective case series. Vet J 2010; 186: 358-363.
6. Berger S, Froehlich W. Stenotrophomonas maltophilia as a causative agent of bacterial infections in the horse: two clinical cases. Pferdeheilkunde 2011; 27: 381-385.
7. Kralova-Kovarikova S, Husnik R, Honzak D, Kohout P, Fictum P. Stenotrophomonas maltophilia urinary tract infections in three dogs: a case report. Vet Med 2012; 57: 380-383.
8. Johnson E, Al-Busaidy R, Hameed M. An outbreak of lymphadenitis associated with Stenotrophomonas (Xanthomonas) maltophilia in Omani goats. J Vet Med Ser B Infect Dis Vet Public Health 2003; 50: 102-104.
9. Anderson SW, Stapp JR, Burns JL, Qin X. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis. J Clin Microbiol 2007; 45: 529-535.
10. Bittar F, Rolain JM. Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients. Clin Microbiol Infect 2010; 16: 809-820.
11. Burdge D, Noble M, Campbell M, Krell V, Speert D. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin Infect Dis 1995; 20: 445-448.
12. Carmody LA, Spilker T, LiPuma JJ. Reassessment of Stenotrophomonas maltophilia phenotype. J Clin Microbiol 2011; 49: 1101-1103.
13. Svensson-Stadler LA, Mihaylova SA, Moore ERB. Stenotrophomonas interspecies differentiation and identification by gyrB sequence analysis. FEMS Microbiol Lett 2012; 327: 15-24.
14. Foster NF, Chang BJ, Riley TV. Evaluation of a modified selective differential medium for the isolation of Stenotrophomonas maltophilia. J Microbiol Methods 2008; 75: 153-155.
15. Goncalves-Vidigal P, Grosse-Onnebrink J, Mellies U, Buer J, Rath PM, Steinmann J. Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance. J Cyst Fibros 2011; 10: 422-427.
16. Kerr K, Denton M, Todd N, Corps C, Kumari P, Hawkey P. A new selective differential medium for isolation of Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis 1996; 15: 607-610.
17. Pinot C, Deredjian A, Nazaret S et al. Identification of Stenotrophomonas maltophilia strains isolated from environmental and clinical samples: a rapid and efficient procedure. J Appl Microbiol 2011; 111: 1185-1193.
18. Hogardt M, Trebesius K, Geiger AM, Hornef M, Rosenecker J, Heesemann J. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol 2000; 38: 818-825.
19. Pellestor F, Paulasova P, Hamamah S. Peptide nucleic acids (PNAs) as diagnostic devices for genetic and cytogenetic analysis. Curr Pharm Des 2008; 14: 2439-2444.
20. Bjarnsholt T, Jensen PO, Fiandaca MJ et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009; 44: 547-558.